Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients

NCT04103645 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Myeloproliferative Neoplasm

Interventions

DRUG: Vactosertib
DRUG: Vactosertib
DRUG: Vactosertib
DRUG: Vactosertib
DRUG: Vactosertib

Sponsor

Weill Medical College of Cornell University